Expanding Use of Continuous Glucose Monitoring Beyond COVID in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 201
- 试验地点
- 1
- 主要终点
- Percentage of Time in Target Glycemic Ranges
研究概览
简要总结
The primary objective of this implementation study is to assess the feasibility of real time continuous glucose monitoring (CGM) implementation using a CGM plus (+) point-of-care (POC) protocol among patients on IV insulin or those with hyperglycemia (>250mg/dl) in the critical care hospital environments.
详细描述
This study analyzes the feasibility of inpatient real time CGM implementation through the use of a CGM + POC protocol as routine care for glycemic monitoring among patients on IV insulin or those with hyperglycemia (>250mg/dl). The investigators will examine the effects on medical intensive care (MICU) patient's (N=100) glycemic control compared to matched historical control patients (N=100) from the MICU who received fingerstick POC.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Sequential
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adults >18 years old,
- •admitted to Ohio State University Wexner Medical Center MICU and
- •have hyperglycemia (glucose >250mg/dl) or are currently on IV insulin.
排除标准
- •Current COVID-19 infection,
- •Refractory shock (Levophed dose >0.5 mcg/kg/min or equivalent)
- •Actively being treated for diabetic ketoacidosis (DKA)
- •Actively being treated for hyperosmolar non-ketoacidosis (HONK)
- •Pitting edema, anasarca, blue or purple discoloration to left upper extremity
- •Treated with high dose acetaminophen (>1 gram Q6 hours)
- •Treated with hydroxyurea
- •Are pregnant, patients
- •Using home insulin pump therapy during hospitalization, or
- •Reside in a corrections institution.
研究组 & 干预措施
Dexcom CGM
Dexcom G6
干预措施: Dexcom G6 (Device)
Historical Controls
Matched historical controls
结局指标
主要结局
Percentage of Time in Target Glycemic Ranges
时间窗: For duration of MICU stay which was an average of 7.6 ± 4.1 days/patient
Percent of time in target glycemic ranges: 100-180 mg/dl, 70-180mg/dl, 140-180mg/d
次要结局
- Percent of Time in Hypoglycemic Ranges(For duration of MICU stay which was an average of 7.6 ± 4.1 days/patient)